Product
rAd26-S
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase I/II Single-Blinded Randomised Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of COVID-19Status: Completed, Estimated PCD: 2022-03-29